SINTX Technologies (SINT) Q3 2024 earnings summary

Executive summary

• Revenue for Q3 2024 increased 18% year-over-year to $0.8M, driven by new orders for silicon nitride aerospace components and government contracts in both Utah and Maryland operations.

• Net loss for Q3 2024 was $6.2M, up from $3.2M in Q3 2023, primarily due to a $4.5M impairment charge related to the shutdown of the armor plant and a $0.4M reduction in force expense.

• The company is evaluating a strategic shift to focus on medical devices, leveraging its advanced ceramics expertise, but this transition is not yet approved by the Board.

Financial highlights

• Product revenue for Q3 2024 rose 118% year-over-year to $0.37M; grant and contract revenue decreased 15% to $0.43M.

• Gross profit for Q3 2024 was $0.59M, up 5% year-over-year.

• Operating expenses for Q3 2024 totaled $7.0M, up 68% year-over-year, mainly due to the $4.5M armor exit costs and $0.4M reduction in force.

• Net loss for the nine months ended September 30, 2024 was $9.3M, compared to $5.9M for the same period in 2023.

Outlook and guidance

• The company requires substantial additional capital to continue operations and fund product development; current resources are insufficient for all planned initiatives.

• Management is actively seeking additional equity or debt financing, but such funding is not guaranteed and may be dilutive.

• The Board and management are reviewing strategic options, including divestitures, acquisitions, and a potential shift to medical devices.